VHealth Insights

Humana reported Q3 2026 revenue of $41.16 billion, up 26.1% year over year, with Medicare Advantage membership reaching 7.19 million. Its Insurance segment recorded a $303 million operating loss.

CMS finalized the CY 2027 Physician Fee Schedule on November 4, 2026. The rule expands ACO cost-sharing options, adjusts conversion factors downward, and launches the Ambulatory Specialty Model.

CMS proposed on October 23, 2026 that ACA Exchange eligibility must be verified before subsidies begin. What health plans, agents, providers, and Exchanges need to prepare for before August 2027.

Molina Healthcare's Q3 2026 earnings, five years of results, Medicaid margin pressure, and the implications for payer leaders.

Elevance Health's Q3 2026 results across five years: a 47.3 percent revenue increase alongside a 26.5 percent decline in operating income, and what payer leaders should watch in the recovery.

Eighteen payers are leaving Medicare Advantage in 2027. CHRISTUS reported a 104.6% medical loss ratio. CarePartners accumulated $67.64 million in losses over four years. Wellmark's Advantage entity lost $76.83 million. This analysis examines the financial evidence behind each departure - and where the public record remains incomplete.

CMS published its 2027 state fact sheets on September 28, 2026. Twenty-eight states have fewer Medicare Advantage plans, 21 have more, and Alaska remains at zero. This analysis examines where the largest changes occurred, what plan counts do and do not reveal, and what carriers, agencies, and providers should do next.

UnitedHealth Group reported $112.7B in Q3 2026 revenue with operating earnings up 52%, even as UnitedHealthcare served 1.8 million fewer medical members. This analysis examines what the results reveal about growth discipline, medical cost management, and what the company must demonstrate in 2027.

CMS preliminary 2027 Star Ratings show the industry-wide 4-plus star member share falling to an estimated 35%. This analysis examines national carrier performance, member-facing measure declines, regional plan variation, and the operational priorities that separated high performers from plans that declined.

On October 5, CMS announced updated Transparency in Coverage regulations to make healthcare pricing information more reliable and easier to use. The changes address cleaner public pricing files, better context for in-network prices, phone-based cost-sharing access, and direct organizational accountability for data accuracy.

The 2027 Annual Enrollment Period brings the largest MOOP increase in Medicare Advantage history, rising premiums after years of compression, new D-SNP integration requirements, and broker compensation caps that are reshaping distribution economics.

A patient sees a primary care physician, a specialist, an imaging center, a hospital, a pharmacy, and a health plan. Each organization may know something important - but the patient is often the only one who knows all of those records exist.

CMS has used the phrase "liberating patient data" to describe its interoperability agenda. Here is what the regulatory framework actually requires, what it costs when it fails, and what healthcare organizations should do operationally.

Medicare Advantage covers 35.2 million people in 2026, while plan exits forced about 2.9 million beneficiaries to change coverage. Here is what carriers, providers, agents, and beneficiaries should prepare for.

The federal government announced a $149.3 million investment to expand telehealth and specialty care across rural Arkansas. Whether it turns into care people can actually use depends on decisions made in the next twelve months.

Value-based care is often described as paying for outcomes instead of volume. That definition is directionally correct, but it leaves out how the money moves, how performance is measured, and what a physician is expected to do differently during a normal workday.

Aetna's newly available commercial prior authorization data shows a consistent pattern across multiple states: substantial denial rates, very low appeal rates, and high reversal rates when providers or patients do appeal.

SelectQuote missed Q4 revenue and earnings estimates, guided to a ~14% revenue decline in FY2027, and expects Medicare Advantage approved policies to fall another 10–15%. But operating cash flow improved by ~$44M year over year.

J.D. Power's 2026 Medicare Advantage study shows satisfaction down 41 points since 2024. We examine trust, onboarding, Special Needs Plans, plan complexity and what operators can improve.

For the first time, health systems have publicly available data on how frequently major insurers approve and deny prior authorization requests. The numbers reveal wide variation by insurer and market - and a high appeal overturn rate that makes denial management a revenue-cycle priority.

UnitedHealth Group is treating artificial intelligence as operating infrastructure across its businesses. The opportunity is significant, but healthcare leaders should judge the strategy by workflow-level outcomes, controls and the experience of patients, providers and employees.

Oscar Health reported revenue up 70.4%, membership up 46.2%, and a dramatic improvement in its medical loss ratio. The stock still fell 11.86%. Here is what investors are watching for the second half of 2026.

Alignment Health reported strong Q2 2026 financial results, yet its stock fell sharply. Here's what investors may be pricing in and what healthcare leaders should watch.

UnitedHealth reached No. 4 on the 2026 Fortune Global 500 with $447.6 billion in revenue, raising questions about vertical integration, transparency, governance and measurable value.

Humana led Medicare Advantage enrollment growth in the second quarter of 2026, but UnitedHealth delivered stronger margin performance. The comparison shows why membership, medical costs, administrative efficiency, quality ratings, and cohort economics must be assessed together.

UnitedHealth Group's second-quarter 2026 earnings recovered sharply even as revenue remained nearly flat and membership declined. The results show how pricing, benefit design, medical-cost controls, portfolio decisions and favorable reserve development contributed to the improvement.

Health insurance may cover fertility preservation when cancer treatment could impair future fertility. Coverage depends on the health plan, state law, medical-necessity documentation, provider network and whether the proposed procedure is established or investigational.

Elevance Health's Q2 2026 operating revenue increased 0.8 percent, while operating margin fell 140 basis points. See what the results mean for payer cost management, Medicaid, Medicare Advantage, Carelon, workflow visibility, and member experience.

The 2027 ACA marketing rules take effect July 20, 2026. Agents, brokers, web-brokers, agencies, and lead vendors must review prohibited practices, vendor accountability, and internal controls before the deadline.

Payer membership growth campaigns scale when eligibility, benefit messaging, compliance, broker governance, sales workflow, provider access, and measurement connect first.

Healthcare organizations are running two AI transformations at once. The governed one is planned. The shadow one is already happening in departments. Here is what payer and provider leaders need to know before the second one creates an incident.

Performance marketing in regulated healthcare markets needs governance across claims, consent, vendors, data use, measurement, compliance, and consumer trust. Here is a practical operating model.

AI will change healthcare jobs by automating repeatable administrative tasks first. Payer and provider leaders should focus on workflow redesign, human oversight, compliance, and measurable operating outcomes.

The health plan industry has optimized distribution. The next frontier is plan alignment, matching consumers to the right plan before they ever reach an agent. Mark Seghers explains why sequencing matters.

Personalized healthcare is moving from broad population averages toward more specific decisions for each patient, member, and consumer. The opportunity is real, but personalization only works when data, workflow, decision rules, compliance, and human judgment are connected.

Most healthcare AI rollouts fail because teams buy tools before fixing workflows, ownership, data visibility, and operating controls. A practical rollout starts with the work.

UnitedHealth Group's Q1 2026 artificial intelligence update offers a practical lesson for healthcare leaders: start with expensive workflows, define the baseline, protect human judgment, and measure whether the work actually improves.

Healthcare AI implementation requires more than tools. Workflow design, data readiness, governance, automation boundaries, and human judgment are the operating layer that turns AI interest into measurable business value.

Cigna, Humana, and AHIP are moving toward standardized prior authorization requirements. The direction is right. But the impact will depend entirely on how those standards are implemented inside real operating environments.

Public payer-provider disputes are becoming more common, but the visible contract fight is usually the last stage of a deeper operational failure. Here is what healthcare leaders should fix before the next dispute reaches the front page.

Medigap loss ratios are rising, and many payers are responding with rate action. That response comes late. The stronger operating move is earlier visibility into claims leakage, tighter coordination across eligibility and recovery, and faster correction before avoidable cost hardens into the next pricing cycle.

Centers for Medicare & Medicaid Services leaders are talking openly about agentic artificial intelligence for Medicare beneficiaries. That may sound like a technology story, but the real issue is trust. In Medicare, a polished answer is not enough. If artificial intelligence is going to help people compare plans, choose doctors, or understand coverage, it needs current data, clear limits, and a simple path to a human when things get complicated.

Healthcare organizations do not need more dashboards. They need clearer visibility, faster decisions, and stronger compliance across the workflows that drive cost, revenue, utilization, workforce performance, and operational execution...

McKinsey's analysis shows a meaningful near-term AI opportunity for payers, but the real constraint is not technology alone. It is workflow design, data quality, adoption, governance, and the ability to scale. Those same pressures are now shaping provider cost control as well.